-
Recent Posts
- Call for Papers & Thematic Issues—Current Microwave Chemistry
- Machine learning and artificial intelligence in physiologically based pharmacokinetic (PBPK) modeling
- Fusion Breakthrough May Be Game-Changer for Energy
- HUGO Gene Nomenclatre Committee (HGNC) Autumn NewsLetter
- mRNA 5’ terminal sequences drive 200-fold differences in expression through effects on synthesis, translation and decay
Recent Comments
Archives
- February 2023
- December 2022
- November 2022
- October 2022
- September 2022
- August 2022
- July 2022
- June 2022
- May 2022
- April 2022
- March 2022
- February 2022
- November 2021
- October 2021
- September 2021
- August 2021
- July 2021
- June 2021
- May 2021
- March 2021
- February 2021
- January 2021
- December 2020
- November 2020
- October 2020
- September 2020
- August 2020
- July 2020
- June 2020
- May 2020
- April 2020
- March 2020
- February 2020
- January 2020
- December 2019
- November 2019
- October 2019
- September 2019
- August 2019
- July 2019
- June 2019
- May 2019
- April 2019
- March 2019
- February 2019
- January 2019
- December 2018
- November 2018
- October 2018
- September 2018
- August 2018
- July 2018
- June 2018
- May 2018
- April 2018
- March 2018
- February 2018
- January 2018
- December 2017
- November 2017
- October 2017
- September 2017
- August 2017
- July 2017
- June 2017
- May 2017
- April 2017
- March 2017
- February 2017
- January 2017
- December 2016
- November 2016
- October 2016
- September 2016
- August 2016
- July 2016
- June 2016
- May 2016
- April 2016
- March 2016
- February 2016
- January 2016
- September 2006
- September 1995
- August 1995
- January 1995
- September 1994
- March 1994
- January 1994
Categories
Meta
Monthly Archives: December 2020
An mRNA Vaccine against SARS-CoV-2: Phase I findings
For those interested, this article see attached just appeared in N Engl J Med This article describes the Phase 1, dose-escalation, open-label trial — including 45 healthy adults, 18 to 55 years of age, who received two vaccinations, 28 days … Continue reading
Posted in Center for Environmental Genetics
Comments Off on An mRNA Vaccine against SARS-CoV-2: Phase I findings